论文部分内容阅读
本文随机选择100例地高辛血药浓度监测病人的病案记录，分别就性别、年龄、疾病状态、合并用药诸因素对用药者体内地高辛血药浓度的影响进行了生物统计分析。数据应用POMS医用统计学软件进行方差分析，结果显示：性别、肝功能、肺心病及合并用药对地高辛血药浓度无显著影响（P＞0.05）;年龄老化及疾病状态中肾功能不全、糖尿病、肺部感染对地高辛血药浓度有显著影响（P＜0.01）。
This paper randomly selected 100 cases of digoxin plasma concentration monitoring patient record of the case, respectively, on the gender, age, disease status, the combined use of drug factors on the drug in vivo digoxin plasma concentrations were biostatistical analysis. Data were analyzed by ANOVA with POMS medical statistics software. The results showed that gender, liver function, pulmonary heart disease and combination therapy had no significant effect on digoxin plasma concentration (P> 0.05); age and disease status of renal insufficiency, Diabetes mellitus and lung infection had significant effects on digoxin plasma concentration (P <0.01).